FDA issued a Warning Letter to Agila Specialties Private Limited on 9/9/2013 for a previous inspection.
483 Mylan Labs Limited, Speciality Formulation Facility Apr 2016

483 Mylan Labs Limited, Speciality Formulation Facility Apr 2016

Jose Melendez FDA, Parul Patel FDA$119.00 - Available Now

FDA investigators audited the Mylan Labs Limited, Speciality Formulation Facility - Bangalore, India facility and issued inspectional observations (via FDA 483) on 13 Apr 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Apr 2016
  • Location: Bangalore, India
  • FEI: 3007648351
Add To Cart